Cubist Systematic Strategies, LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 104 filers reported holding XENON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$69,969
+902.6%
1,955
+1004.5%
0.00%
Q4 2022$6,979
-99.0%
177
-99.1%
0.00%
-100.0%
Q3 2022$730,000
-54.4%
20,211
-61.6%
0.00%
-60.0%
Q2 2022$1,602,000
-29.2%
52,678
-28.9%
0.01%
-47.4%
Q1 2022$2,263,000
+398.5%
74,039
+409.2%
0.02%
+375.0%
Q4 2021$454,000
+275.2%
14,541
+84.3%
0.00%
+100.0%
Q3 2021$121,000
+255.9%
7,888
+328.5%
0.00%
Q2 2021$34,000
-66.0%
1,841
-67.2%
0.00%
-100.0%
Q1 2021$100,000
+8.7%
5,611
-6.4%
0.00%0.0%
Q4 2020$92,000
+43.8%
5,993
+3.0%
0.00%0.0%
Q3 2020$64,000
-66.8%
5,820
-62.2%
0.00%
-66.7%
Q2 2020$193,000
+4.3%
15,410
-5.5%
0.00%
-40.0%
Q1 2020$185,000
-44.8%
16,307
-36.1%
0.01%
-16.7%
Q4 2019$335,000
+2133.3%
25,515
+1452.0%
0.01%
Q3 2019$15,000
-65.9%
1,644
-63.2%
0.00%
-100.0%
Q2 2019$44,000
-39.7%
4,470
-37.6%
0.00%
-50.0%
Q1 2019$73,000
+78.0%
7,160
+10.4%
0.00%0.0%
Q4 2018$41,000
+583.3%
6,485
+980.8%
0.00%
Q2 2018$6,000
-45.5%
600
-72.7%
0.00%
-100.0%
Q1 2018$11,0002,200
+2100.0%
0.00%
Q4 2017$0
-100.0%
100
-93.1%
0.00%
-100.0%
Q3 2015$12,000
-67.6%
1,440
-54.7%
0.00%
-50.0%
Q2 2015$37,000
+5.7%
3,178
+52.1%
0.00%0.0%
Q1 2015$35,0002,0890.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders